Loren Data's FBO Daily™

fbodaily.com
Home Today's FBO Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JUNE 07, 2013 FBO #4213
SOLICITATION NOTICE

P -- Special Studies and Analysis

Notice Date
6/5/2013
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, Maryland, 20817
 
ZIP Code
20817
 
Solicitation Number
NIAID-NOI13-D1631050
 
Archive Date
7/5/2013
 
Point of Contact
Lisa Hinton, Phone: 301.402.5803, John - Foley, Phone: 301-402-2284
 
E-Mail Address
hintonl@mail.nih.gov, jfoley@niaid.nih.gov
(hintonl@mail.nih.gov, jfoley@niaid.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a combined/synopsis solicitation Notice of Intent for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are not being requested and a written solicitation will not be issued. The solicitation number for this acquisition is NIAIDNOI1631064 and the solicitation is being issued as a Notice of Intent to The International TB Research Center, Masan, South Korea. This solicitation document and its incorporated provisions are those in effect through the Federal Acquisition Circular (FAC 2005-66, Feb 28, 2013). This acquisition will be processed under Simplified Acquisition Procedures (SAP) and it not a Small Business Set-Aside. The North American Industry Classification System (NAICS) Code 541711, which has a business size standard of 500. The services are to be provided at the International Tuberculosis Research Center, Masan, and Republic of Korea. In order to accomplish the goals of the project, the following types of services are required but not limited to: Bacteriological services (microbial growth and quantitation in several media, macrophage bactericidal assays); Pharmacokinetics assessments; Drug Sensitivity testing services; Molecular analysis of TB isolates and other related services as necessary. ITRC proactively supports investigators in Korea who conduct MDR-TB research and provides clinical trial expertise that is internationally compliant with Good Clinical Practice (GCP) and support of the ethical conduct of CRFs and databases on a monthly basis. Data will be included from the following assays: drug sensitivity testing, real time PCR, sequencing, and genotyping. Data entered into the databases will be considered as a portion of the regular deliverables and are not required to be delivered to NIAID a second time if the electronic exchange of data is functioning. Non-document deliverables include but not limited to blood, RNA, sputum, urine, bacterial strains, host tissues and other materials specified in the SOW and associated clinical protocols and exempted activities reviewed by the NIH and NMTH ethics committees. These items will be shipped to NIAID on a quarterly schedule or more frequently as requested by the Project Officer. The FAR provisions and clauses that apply to this acquisition are: FAR 52.212-1, Buy American Act-Supplies; FAR 52.212-3, Offeror Representations and Certification - Commercial; FAR 52.212-4, Contract Terms and Conditions - Commercial Items; 52.212-5, Contract Terms and Conditions required to Implement Statutes or Executive Orders - Commercial Items; FAR 52.204-7; Instructions to Offers Commercial Items; FAR 52.212.3 Offeror Representations and Certifications Commercial Items; FAR 52.212-4 Contractor Terms and Conditions Commercial Items; FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items. All of the terms and conditions pertaining to this are available upon request by telephone to Ms. Lisa Hinton at (301) 402-5803. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely to the discretion of the Government. Comments to this announcement, referencing notification number NIAIDNOI13-D1631050 must be submitted no later than 5:00 PM Eastern Time (ET), June 20, 2013 to Ms. Lisa Hinton. For delivery through the Postal Service, the address is NIH/NIAID/AMOB, 10401 Fernwood Drive, Suite 2NE52B/MSC 4812, Bethesda, Maryland 20892-4812. Electronic submission will not be accepted. In order to be considered for an award, offeror must have completed the online electronic Representations and Certifications located at http://orca.bpn.gov/ in accordance with FAR 4.1201(a). By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the CCR at: www.ccr.gov/ prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation. [Note: Lack of registration in the Central Contractor Registration will make an offeror ineligible for award.]
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/NIAID-NOI13-D1631050/listing.html)
 
Place of Performance
Address: National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN03081382-W 20130607/130606002607-e5734e4ab2eadae882cb1e9c1c522e39 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2016, Loren Data Corp.